Finally, it is known that insulin resistance increases with increasing heart failure severity [31], and although the treatment effect on HbA1c remained statistically significant after adjustment for changes in levels of NT-proBNP, it remains plausible that sacubitril/valsartan improved measures of glycemia by reducing worsening of heart failure progression over time. This evidence concerns the gene NPPB and Insulin resistance.